BridgeBio Pharma, Inc. ( BBIO) - Stock Earnings
BBIO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 28, 2026, midnight | — / — | — | — / — | — |
BBIO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -197.2 million USD | 154.2 million USD |
| 2026Q1 | -164.0 million USD | 194.5 million USD |
| 2026Q2 | -152.2 million USD | 222.4 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
BBIO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -643.2 million USD | 9.3 million USD |
| 2024 | -535.8 million USD | 221.9 million USD |
| 2025 | -729.3 million USD | 502.1 million USD |
| 2026 Est. | — | — |
BBIO
Price: $65.35
Earnings Per Share: -3.56 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.7 million
Market Capitalization: 13.2 billion